Application of therapeutic plasma exchange in patients having severe fever with thrombocytopenia syndrome

• Published in: The Korean journal of internal medicine Vol. 34; no. 4; pp. 902 - 909
• Main Authors: Yoo, Jeong Rae, Kim, Sun Hyung, Kim, Young Ree, Lee, Keun Hwa, Oh, Won Sup, Heo, Sang Taek
• Format: Journal Article
• Language: English
• Published: Korea (South) The Korean Association of Internal Medicine 01.07.2019; 대한내과학회
• Subjects: Aged; Bunyaviridae Infections - blood; Bunyaviridae Infections - diagnosis; Bunyaviridae Infections - therapy; Bunyaviridae Infections - virology; Disease Progression; Female; Fever - blood; Fever - diagnosis; Fever - therapy; Fever - virology; Humans; Male; Middle Aged; Original; Phlebovirus - pathogenicity; Plasma Exchange; Retrospective Studies; severe fever with thrombocytopenia syndrome; Severity of Illness Index; therapeutics; Thrombocytopenia - blood; Thrombocytopenia - diagnosis; Thrombocytopenia - therapy; Thrombocytopenia - virology; Treatment Outcome; Viral Load; 내과학; Severe fever with thrombocytopenia syndrome; Plasma exchange; Therapeutics
• ISSN: 1226-3303; 2005-6648
• DOI: 10.3904/kjim.2016.194

Severe fever with thrombocytopenia syndrome (SFTS) is a viral hemorrhagic fever with a high fatality rate. However, effective treatments for SFTS cases not responded to supportive therapy have not been established. Herein, we introduced the therapeutic plasma exchange (TPE) in SFTS patients in a tertiary hospital between 2013 and 2015. TPE was performed in patients with rapidly progressing SFTS. Clinical, laboratory, and virological parameters were compared before and after TPE. Among 27 confirmed SFTS patients, two patients were treated with TPE and ribavirin combination in May 2013, then, 14 patients with rapidly progressing SFTS patients were treated with only TPE from June 2013 to September 2015: their median age was 58 years (interquartile range, 50 to 70) and eight (57.1%) were male. Body temperature, pressure-adjusted heart rate, white blood cell and platelet counts, coagulation profile, serum creatinine, and multiple organ dysfunction score improved immediately after TPE. In addition, the mean cyclic threshold value of real-time reverse transcriptase polymerase chain reaction for SFTS virus after TPE (mean ± standard deviation, 31.3 ± 2.9) was significantly higher than that before TPE (26.5 ± 2.9; p < 0.001), indicating that serum viral loads decreased after TPE. Finally, 13 of 14 TPE-treated patients (92.8%) recovered from rapidly progressing SFTS without sequelae. SFTS patients treated with TPE showed improvements in clinical, laboratory, and virological parameters. These results suggest that TPE would be a therapeutic modality as rescue therapy in patients with rapidly progressing SFTS.